There are two main isoforms of the ER, the alpha (ER-α) and the beta (ER-β) isoform, which have been shown to play opposing roles in the initiation and progression of breast cancers; the alpha isoform promotes tumor formation and progression, while the beta isoform takes on the role of a tumor suppressor [67]. Here, ESR2 is linked to neoplasm.